Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Identifieur interne : 000734 ( PubMed/Curation ); précédent : 000733; suivant : 000735

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Auteurs : Sharon E. Frey [États-Unis] ; David I. Bernstein [États-Unis] ; Rebecca C. Brady [États-Unis] ; Wendy A. Keitel [États-Unis] ; Hana El Sahly [États-Unis] ; Nadine Georges Rouphael [États-Unis] ; Mark J. Mulligan [États-Unis] ; Robert L. Atmar [États-Unis] ; Srilatha Edupuganti [États-Unis] ; Shital M. Patel [États-Unis] ; Michelle Dickey [États-Unis] ; Irene Graham [États-Unis] ; Edwin L. Anderson [États-Unis] ; Diana L. Noah [États-Unis] ; Heather Hill [États-Unis] ; Mark Wolff [États-Unis] ; Robert B. Belshe [États-Unis]

Source :

RBID : pubmed:25444805

Descripteurs français

English descriptors

Abstract

During the 2009 influenza pandemic both seasonal and 2009 pandemic vaccines were recommended. We conducted a randomized trial of monovalent 2009-H1N1 vaccine and seasonal trivalent inactivated influenza vaccine (IIV3) given sequentially or concurrently to adults.

DOI: 10.1016/j.vaccine.2014.10.083
PubMed: 25444805

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:25444805

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.</title>
<author>
<name sortKey="Frey, Sharon E" sort="Frey, Sharon E" uniqKey="Frey S" first="Sharon E" last="Frey">Sharon E. Frey</name>
<affiliation wicri:level="1">
<nlm:affiliation>Saint Louis University School of Medicine, United States. Electronic address: freyse@slu.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Saint Louis University School of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bernstein, David I" sort="Bernstein, David I" uniqKey="Bernstein D" first="David I" last="Bernstein">David I. Bernstein</name>
<affiliation wicri:level="1">
<nlm:affiliation>Cincinnati Children's Hospital Medical Center, University of Cincinnati, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cincinnati Children's Hospital Medical Center, University of Cincinnati</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Brady, Rebecca C" sort="Brady, Rebecca C" uniqKey="Brady R" first="Rebecca C" last="Brady">Rebecca C. Brady</name>
<affiliation wicri:level="1">
<nlm:affiliation>Cincinnati Children's Hospital Medical Center, University of Cincinnati, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cincinnati Children's Hospital Medical Center, University of Cincinnati</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Keitel, Wendy A" sort="Keitel, Wendy A" uniqKey="Keitel W" first="Wendy A" last="Keitel">Wendy A. Keitel</name>
<affiliation wicri:level="1">
<nlm:affiliation>Baylor College of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baylor College of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="El Sahly, Hana" sort="El Sahly, Hana" uniqKey="El Sahly H" first="Hana" last="El Sahly">Hana El Sahly</name>
<affiliation wicri:level="1">
<nlm:affiliation>Baylor College of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baylor College of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Rouphael, Nadine Georges" sort="Rouphael, Nadine Georges" uniqKey="Rouphael N" first="Nadine Georges" last="Rouphael">Nadine Georges Rouphael</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Mulligan, Mark J" sort="Mulligan, Mark J" uniqKey="Mulligan M" first="Mark J" last="Mulligan">Mark J. Mulligan</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Atmar, Robert L" sort="Atmar, Robert L" uniqKey="Atmar R" first="Robert L" last="Atmar">Robert L. Atmar</name>
<affiliation wicri:level="1">
<nlm:affiliation>Baylor College of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baylor College of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Edupuganti, Srilatha" sort="Edupuganti, Srilatha" uniqKey="Edupuganti S" first="Srilatha" last="Edupuganti">Srilatha Edupuganti</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Patel, Shital M" sort="Patel, Shital M" uniqKey="Patel S" first="Shital M" last="Patel">Shital M. Patel</name>
<affiliation wicri:level="1">
<nlm:affiliation>Baylor College of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baylor College of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Dickey, Michelle" sort="Dickey, Michelle" uniqKey="Dickey M" first="Michelle" last="Dickey">Michelle Dickey</name>
<affiliation wicri:level="1">
<nlm:affiliation>Cincinnati Children's Hospital Medical Center, University of Cincinnati, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cincinnati Children's Hospital Medical Center, University of Cincinnati</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Graham, Irene" sort="Graham, Irene" uniqKey="Graham I" first="Irene" last="Graham">Irene Graham</name>
<affiliation wicri:level="1">
<nlm:affiliation>Saint Louis University School of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Saint Louis University School of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Anderson, Edwin L" sort="Anderson, Edwin L" uniqKey="Anderson E" first="Edwin L" last="Anderson">Edwin L. Anderson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Saint Louis University School of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Saint Louis University School of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Noah, Diana L" sort="Noah, Diana L" uniqKey="Noah D" first="Diana L" last="Noah">Diana L. Noah</name>
<affiliation wicri:level="1">
<nlm:affiliation>Southern Research Institute, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Southern Research Institute</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Hill, Heather" sort="Hill, Heather" uniqKey="Hill H" first="Heather" last="Hill">Heather Hill</name>
<affiliation wicri:level="1">
<nlm:affiliation>The EMMES Corporation, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The EMMES Corporation</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wolff, Mark" sort="Wolff, Mark" uniqKey="Wolff M" first="Mark" last="Wolff">Mark Wolff</name>
<affiliation wicri:level="1">
<nlm:affiliation>The EMMES Corporation, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The EMMES Corporation</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Belshe, Robert B" sort="Belshe, Robert B" uniqKey="Belshe R" first="Robert B" last="Belshe">Robert B. Belshe</name>
<affiliation wicri:level="1">
<nlm:affiliation>Saint Louis University School of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Saint Louis University School of Medicine</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25444805</idno>
<idno type="pmid">25444805</idno>
<idno type="doi">10.1016/j.vaccine.2014.10.083</idno>
<idno type="wicri:Area/PubMed/Corpus">000734</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000734</idno>
<idno type="wicri:Area/PubMed/Curation">000734</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000734</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.</title>
<author>
<name sortKey="Frey, Sharon E" sort="Frey, Sharon E" uniqKey="Frey S" first="Sharon E" last="Frey">Sharon E. Frey</name>
<affiliation wicri:level="1">
<nlm:affiliation>Saint Louis University School of Medicine, United States. Electronic address: freyse@slu.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Saint Louis University School of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bernstein, David I" sort="Bernstein, David I" uniqKey="Bernstein D" first="David I" last="Bernstein">David I. Bernstein</name>
<affiliation wicri:level="1">
<nlm:affiliation>Cincinnati Children's Hospital Medical Center, University of Cincinnati, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cincinnati Children's Hospital Medical Center, University of Cincinnati</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Brady, Rebecca C" sort="Brady, Rebecca C" uniqKey="Brady R" first="Rebecca C" last="Brady">Rebecca C. Brady</name>
<affiliation wicri:level="1">
<nlm:affiliation>Cincinnati Children's Hospital Medical Center, University of Cincinnati, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cincinnati Children's Hospital Medical Center, University of Cincinnati</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Keitel, Wendy A" sort="Keitel, Wendy A" uniqKey="Keitel W" first="Wendy A" last="Keitel">Wendy A. Keitel</name>
<affiliation wicri:level="1">
<nlm:affiliation>Baylor College of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baylor College of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="El Sahly, Hana" sort="El Sahly, Hana" uniqKey="El Sahly H" first="Hana" last="El Sahly">Hana El Sahly</name>
<affiliation wicri:level="1">
<nlm:affiliation>Baylor College of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baylor College of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Rouphael, Nadine Georges" sort="Rouphael, Nadine Georges" uniqKey="Rouphael N" first="Nadine Georges" last="Rouphael">Nadine Georges Rouphael</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Mulligan, Mark J" sort="Mulligan, Mark J" uniqKey="Mulligan M" first="Mark J" last="Mulligan">Mark J. Mulligan</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Atmar, Robert L" sort="Atmar, Robert L" uniqKey="Atmar R" first="Robert L" last="Atmar">Robert L. Atmar</name>
<affiliation wicri:level="1">
<nlm:affiliation>Baylor College of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baylor College of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Edupuganti, Srilatha" sort="Edupuganti, Srilatha" uniqKey="Edupuganti S" first="Srilatha" last="Edupuganti">Srilatha Edupuganti</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Patel, Shital M" sort="Patel, Shital M" uniqKey="Patel S" first="Shital M" last="Patel">Shital M. Patel</name>
<affiliation wicri:level="1">
<nlm:affiliation>Baylor College of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baylor College of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Dickey, Michelle" sort="Dickey, Michelle" uniqKey="Dickey M" first="Michelle" last="Dickey">Michelle Dickey</name>
<affiliation wicri:level="1">
<nlm:affiliation>Cincinnati Children's Hospital Medical Center, University of Cincinnati, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cincinnati Children's Hospital Medical Center, University of Cincinnati</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Graham, Irene" sort="Graham, Irene" uniqKey="Graham I" first="Irene" last="Graham">Irene Graham</name>
<affiliation wicri:level="1">
<nlm:affiliation>Saint Louis University School of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Saint Louis University School of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Anderson, Edwin L" sort="Anderson, Edwin L" uniqKey="Anderson E" first="Edwin L" last="Anderson">Edwin L. Anderson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Saint Louis University School of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Saint Louis University School of Medicine</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Noah, Diana L" sort="Noah, Diana L" uniqKey="Noah D" first="Diana L" last="Noah">Diana L. Noah</name>
<affiliation wicri:level="1">
<nlm:affiliation>Southern Research Institute, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Southern Research Institute</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Hill, Heather" sort="Hill, Heather" uniqKey="Hill H" first="Heather" last="Hill">Heather Hill</name>
<affiliation wicri:level="1">
<nlm:affiliation>The EMMES Corporation, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The EMMES Corporation</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wolff, Mark" sort="Wolff, Mark" uniqKey="Wolff M" first="Mark" last="Wolff">Mark Wolff</name>
<affiliation wicri:level="1">
<nlm:affiliation>The EMMES Corporation, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The EMMES Corporation</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Belshe, Robert B" sort="Belshe, Robert B" uniqKey="Belshe R" first="Robert B" last="Belshe">Robert B. Belshe</name>
<affiliation wicri:level="1">
<nlm:affiliation>Saint Louis University School of Medicine, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Saint Louis University School of Medicine</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Vaccine</title>
<idno type="eISSN">1873-2518</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antibodies, Viral (blood)</term>
<term>Female</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Humans</term>
<term>Immunization Schedule</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza Vaccines (adverse effects)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Injections, Intramuscular</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Placebos (administration & dosage)</term>
<term>Vaccination (adverse effects)</term>
<term>Vaccination (methods)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Anticorps antiviraux (sang)</term>
<term>Calendrier vaccinal</term>
<term>Femelle</term>
<term>Grippe humaine ()</term>
<term>Humains</term>
<term>Injections musculaires</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Placebo (administration et posologie)</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Vaccination ()</term>
<term>Vaccination (effets indésirables)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Vaccins antigrippaux (effets indésirables)</term>
<term>Vaccins antigrippaux (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Influenza Vaccines</term>
<term>Placebos</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Placebo</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Vaccination</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Humans</term>
<term>Immunization Schedule</term>
<term>Injections, Intramuscular</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Calendrier vaccinal</term>
<term>Femelle</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Injections musculaires</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Vaccination</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">During the 2009 influenza pandemic both seasonal and 2009 pandemic vaccines were recommended. We conducted a randomized trial of monovalent 2009-H1N1 vaccine and seasonal trivalent inactivated influenza vaccine (IIV3) given sequentially or concurrently to adults.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">25444805</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>07</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-2518</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>33</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jan</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Vaccine</Title>
<ISOAbbreviation>Vaccine</ISOAbbreviation>
</Journal>
<ArticleTitle>Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.</ArticleTitle>
<Pagination>
<MedlinePgn>163-73</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2014.10.083</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0264-410X(14)01502-3</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">During the 2009 influenza pandemic both seasonal and 2009 pandemic vaccines were recommended. We conducted a randomized trial of monovalent 2009-H1N1 vaccine and seasonal trivalent inactivated influenza vaccine (IIV3) given sequentially or concurrently to adults.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Adults randomized to 4 study groups and stratified by age (18-64 and ≥65 years) received 1 dose of seasonal IIV3 or placebo and 2 doses of 2009-H1N1 vaccine or placebo in one of 4 combinations, i.e., H1N1+Placebo/H1N1+Placebo/IIV3 (HP/HP/V3), H1N1+IIV3/H1N1+Placebo/Placebo (HV3/HP/P), H1N1+Placebo/H1N1+IIV3/Placebo (HP/HV3/P), and IIV3+Placebo/H1N1+Placebo/H1N1 (V3P/HP/H). Intramuscular injections were given three times at 21 day intervals. Sera for antibody assays were obtained prior to and 21 days after each vaccination. Reactogenicity and adverse events were monitored.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight hundred-five (805) adults were enrolled. All combinations of vaccines were safe and well tolerated. In general, one dose of 2009-H1N1 and one dose of IIV3, regardless of sequence or concurrency of administration, were immunogenic in adults. There were no significant differences in geometric mean titers (GMT) or the proportions of subjects with ≥4-fold rise in antibody responses and titers ≥40 for any vaccine group or between age strata for 2009-H1N1 after the first or second dose, although the vaccine sequence affected the titers to the IIV3 antigens. Hemagglutination inhibition antibody (HAI) GMTs against 2009-H1N1 for the combined age strata 21 days after the first 2009-H1N1 dose were 190.4, 182.1, 232.9 and 157.5 for HP/HP/V3, HV3/HP/P, HP/HV3/P and V3P/HP/H, respectively. While IIV3 GMTs were adequate they were generally lower than the 2009-H1N1 GMTs. In a subset of subjects, there was good correlation between HAI and microneutralization (MN) titers (Spearman's correlation coefficient 0.92).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">All vaccine combinations were generally well tolerated. Immune responses to one dose of 2009-H1N1 were adequate regardless of the sequence of vaccination in all age groups, but the sequence affected titers to IIV3 antigens.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Frey</LastName>
<ForeName>Sharon E</ForeName>
<Initials>SE</Initials>
<AffiliationInfo>
<Affiliation>Saint Louis University School of Medicine, United States. Electronic address: freyse@slu.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bernstein</LastName>
<ForeName>David I</ForeName>
<Initials>DI</Initials>
<AffiliationInfo>
<Affiliation>Cincinnati Children's Hospital Medical Center, University of Cincinnati, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brady</LastName>
<ForeName>Rebecca C</ForeName>
<Initials>RC</Initials>
<AffiliationInfo>
<Affiliation>Cincinnati Children's Hospital Medical Center, University of Cincinnati, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Keitel</LastName>
<ForeName>Wendy A</ForeName>
<Initials>WA</Initials>
<AffiliationInfo>
<Affiliation>Baylor College of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>El Sahly</LastName>
<ForeName>Hana</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Baylor College of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rouphael</LastName>
<ForeName>Nadine Georges</ForeName>
<Initials>NG</Initials>
<AffiliationInfo>
<Affiliation>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mulligan</LastName>
<ForeName>Mark J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo>
<Affiliation>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Atmar</LastName>
<ForeName>Robert L</ForeName>
<Initials>RL</Initials>
<AffiliationInfo>
<Affiliation>Baylor College of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Edupuganti</LastName>
<ForeName>Srilatha</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>The Hope Clinic of the Emory Vaccine Center, Department of Medicine, Emory University School of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Patel</LastName>
<ForeName>Shital M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo>
<Affiliation>Baylor College of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dickey</LastName>
<ForeName>Michelle</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Cincinnati Children's Hospital Medical Center, University of Cincinnati, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Graham</LastName>
<ForeName>Irene</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Saint Louis University School of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Anderson</LastName>
<ForeName>Edwin L</ForeName>
<Initials>EL</Initials>
<AffiliationInfo>
<Affiliation>Saint Louis University School of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Noah</LastName>
<ForeName>Diana L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>Southern Research Institute, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hill</LastName>
<ForeName>Heather</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>The EMMES Corporation, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wolff</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>The EMMES Corporation, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Belshe</LastName>
<ForeName>Robert B</ForeName>
<Initials>RB</Initials>
<AffiliationInfo>
<Affiliation>Saint Louis University School of Medicine, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>HHSN272200800006C</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN272200800006C</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN272200800002C</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN272200800002C</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN272200800013C</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN272200800005C</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN272200800003C</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN272200800003C</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N01AI30063</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN272200800005C</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN272200800013C</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Vaccine</MedlineTA>
<NlmUniqueID>8406899</NlmUniqueID>
<ISSNLinking>0264-410X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010919">Placebos</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006385" MajorTopicYN="N">Hemagglutination Inhibition Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007115" MajorTopicYN="Y">Immunization Schedule</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007273" MajorTopicYN="N">Injections, Intramuscular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">2009-H1N1</Keyword>
<Keyword MajorTopicYN="N">Adults</Keyword>
<Keyword MajorTopicYN="N">Concurrent</Keyword>
<Keyword MajorTopicYN="N">Elderly</Keyword>
<Keyword MajorTopicYN="N">HAI</Keyword>
<Keyword MajorTopicYN="N">Influenza vaccine</Keyword>
<Keyword MajorTopicYN="N">Microneutralization</Keyword>
<Keyword MajorTopicYN="N">Pandemic</Keyword>
<Keyword MajorTopicYN="N">Seasonal IIV3</Keyword>
<Keyword MajorTopicYN="N">Sequential</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>06</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2014</Year>
<Month>10</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2014</Year>
<Month>10</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>7</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25444805</ArticleId>
<ArticleId IdType="pii">S0264-410X(14)01502-3</ArticleId>
<ArticleId IdType="doi">10.1016/j.vaccine.2014.10.083</ArticleId>
<ArticleId IdType="pmc">PMC4293632</ArticleId>
<ArticleId IdType="mid">NIHMS643314</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>JAMA. 2010 Jan 6;303(1):37-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20026597</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Dec 17;361(25):2424-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19745215</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2010 Jan 2;375(9708):56-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20018364</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2010 Jan 2;375(9708):49-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20018367</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 Apr 1;201(7):984-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20187740</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2010 Dec 16;29(2):266-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21034828</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2010 Dec 16;363(25):2416-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21158658</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Vaccine Immunol. 2011 Sep;18(9):1503-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21795458</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Immunol. 2011 Nov;55(11):783-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21895745</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011;6(11):e27214</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22087267</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2012 Jun 13;30(28):4240-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22537984</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2012 Sep 15;206(6):811-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22782949</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2012 Sep 15;206(6):828-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22802432</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2012 Oct 5;30(45):6483-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22885014</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 Nov 1;202(9):1327-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20874515</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010;5(10):e13755</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21060780</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2012 Dec 17;31(1):20-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23131207</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2012;12:162</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22824474</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Geriatr Soc. 1987 Jul;35(7):609-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3584763</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 1999 Apr;37(4):937-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10074505</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Vaccine Immunol. 2009 Apr;16(4):558-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19225073</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2009 May 8;58(17):453-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19444146</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):521-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19478718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Jun 18;360(25):2605-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19423869</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2009 Jul 10;325(5937):197-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19465683</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19745214</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Nov 12;361(20):1935-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19815859</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2012;12:279</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23110320</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Dec 17;361(25):2405-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19745216</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Dec 17;361(25):2414-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19846844</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2010 Jan 28;362(4):370-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20042746</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000734 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000734 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:25444805
   |texte=   Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:25444805" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021